After extensive preparations, which included, among other things, authority applications, contracting of clinics, assembly and installation of the system as well as training of clinical staff, we can announce that the recruitment of study participants in the dose confirmation study begins today. The dose confirmation study will be conducted at one of CTC’s clinics in Uppsala.
“It is fantastic that everything is now ready and that we can start the recruitment of study participants. The goal is to have the first participants on site within the next few months,” says CEO Linda Persson.
📄 Read more in the press release here! (in Swedish)
👇 Listen as Linda Persson, CEO, and Ulrika Axelsson, clinical director, tell more about the recruitment that has begun!
